Michael Gaglia is a Cardiology physician. OpenAlex indexes 204 publications with 2,427 citations (h-index 26); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 Bower Hill Rd
Pittsburgh, PA 152431873
Telephone
412-942-1144Provider last certified this registry record 18 Oct 2023.
Clinical trials
- Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
Sponsor: Medstar Health Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Stryker CorporationProgram year20256 payments
- HEARTFLOW, INC.Program year20252 payments
- Shockwave Medical, IncProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.7%Beta blocker16.8%Metoprolol Succinate37%Metoprolol Tartrate33%Carvedilol26%Sotalol3%Part D<11 patientsStatin15.8%Atorvastatin Calcium76%Rosuvastatin Calcium24%Part D≥87 patients+ 10 more classes in this area
Blood & clotting
19.7%Factor Xa inhibitor11.6%Eliquis93%Xarelto7%Part D<11 patientsP2Y12 inhibitor8.1%Clopidogrel76%Brilinta18%Prasugrel Hcl6%Part D<11 patientsMetabolism & gastrointestinal
7.6%SGLT2 inhibitor4.7%Jardiance59%Farxiga41%Part D<11 patientsPotassium supplement2.2%Potassium Chloride100%Part D≥23 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold
JACC: Cardiovascular Interventions
2016 - Comparison of clinical outcomes with the utilization of monitored anesthesia care vs. general anesthesia in patients undergoing transcatheter aortic valve replacement
Cardiovascular revascularization medicine
2016 - Same-day discharge after coronary stenting and femoral artery device closure: A randomized study in stable and low-risk acute coronary syndrome patients
Cardiovascular revascularization medicine
2016 - Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis
The American Journal of Cardiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”